Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Revenue: 2017-2018

Historic Revenue for Astria Therapeutics (ATXS) over the last 2 years, with Sep 2018 value amounting to -$10,000.

  • Astria Therapeutics' Revenue fell 104.00% to -$10,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $150,000, marking a year-over-year change of. This contributed to the annual value of -$100,000 for FY2018, which is 120.00% down from last year.
  • As of Q3 2018, Astria Therapeutics' Revenue stood at -$10,000, which was up 69.70% from -$33,000 recorded in Q2 2018.
  • In the past 5 years, Astria Therapeutics' Revenue registered a high of $250,000 during Q3 2017, and its lowest value of -$149,000 during Q1 2017.
  • Its 2-year average for Revenue is $17,714, with a median of -$33,000 in 2018.
  • Data for Astria Therapeutics' Revenue shows a peak YoY increase of 74.02% (in 2018) and a maximum YoY decrease of 104.00% (in 2018) over the last 5 years.
  • Astria Therapeutics' Revenue (Quarterly) stood at $250,000 in 2017, then plummeted by 104.00% to -$10,000 in 2018.
  • Its last three reported values are -$10,000 in Q3 2018, -$33,000 for Q2 2018, and -$57,000 during Q1 2018.